[1] RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national Sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet,2020,395(10219):200-211. doi:  10.1016/S0140-6736(19)32989-7
[2] Center for Disease Control and Prevention(CDC). Sepsis 2021 [J/OL].https://www.cdc.gov/sepsis/.
[3] SCHULTZ M J, DUNSER M W, DONDORP A M, et al. Current challenges in the management of Sepsis in ICUs in resource-poor settings and suggestions for the future[J]. Intensive Care Med,2019,43(5):612-624.
[4] World Health Organization (WHO). Sepsis 2018 [J/OL]. https://www.who.int/health-topics/sepsis.
[5] PORTE R, DAVOUDIAN S, ASGARI F, et al. The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and Sepsis[J]. Front Immunol,2019,10:794. doi:  10.3389/fimmu.2019.00794
[6] Sabry A, Ibrahim M, Khashana A, et al. Assessment of pentraxin 3 in a systemic inflammatory response occurring with neonatal bacterial infection [J/OL]. J Neonatal Perinatal Med, 2021 Jan 28. https://content.iospress.com/ articles/journal-of-neonatal-perinatal-medicine/npm200550.
[7] FAHMEY S S, MOSTAFA N. Pentraxin 3 as a novel diagnostic marker in neonatal Sepsis[J]. J Neonatal Perinatal Med,2019,12(4):437-442.
[8] HAMED S, BEHNES M, PAULY D, et al. Pentraxin-3 predicts short- and mid-term mortality in patients with Sepsis and septic shock during intensive care treatment[J]. Clin Lab,2018,64(6):999-1011.
[9] HANSEN C B, BAYARRI-OLMOS R, KRISTENSEN M K, et al. Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients[J]. J Infect,2020,80(4):378-387. doi:  10.1016/j.jinf.2020.01.010
[10] TIAN R, WANG X L, PAN T T, et al. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of Sepsis and septic shock[J]. Scand J Immunol,2019,90(6):e12823.
[11] HU C, ZHOU Y, LIU C, et al. Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with Sepsis and septic shock[J]. Oncotarget,2018,9(4):5125-5136. doi:  10.18632/oncotarget.23701
[12] SPOTO S, NOBILE E, CARNÀ E P R, et al. Best diagnostic accuracy of Sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU[J]. Sci Rep,2020,10(1):16605. doi:  10.1038/s41598-020-73676-y
[13] LEMASLE L, BLET A, GEVEN C, et al. Bioactive adrenomedullin, organ support therapies, and survival in the critically ill: results from the French and European outcome registry in ICU study[J]. Crit Care Med,2020,48(1):49-55.
[14] BUENDGENS L, YAGMUR E, GINSBERG A, et al. Midregional proadrenomedullin (MRproADM) serum levels in critically ill patients are associated with short-term and overall mortality during a two-year follow-up[J]. Mediat Inflamm,2020,2020:7184803.
[15] DAGA M K, MAWARI G, KUMAR L, et al. Adrenomedullin and its possible role in improved survival in female patients with Sepsis: a study in south east Asian region[J]. Indian J Crit Care Med,2020,24(12):1180-1184. doi:  10.5005/jp-journals-10071-23672
[16] AJITH KUMAR A K. Adrenomedullin in Sepsis: finally, a friend or an enemy? Indian J Crit Care Med,2020,24(12):1151-1153. doi:  10.5005/jp-journals-10071-23669
[17] LEE W L. Reply to mehmood: adrenomedullin: a double-edged sword in septic shock and heart failure therapeutics? Am J Respir Crit Care Med,2020,201(9):1165.
[18] RUANGSOMBOON O, PANJAIKAEW P, MONSOMBOON A, et al. Diagnostic and prognostic utility of presepsin for Sepsis in very elderly patients in the emergency department[J]. Clin Chim Acta,2020,510:723-732. doi:  10.1016/j.cca.2020.09.014
[19] LEE J, KIM S, KIM K H, et al. The association between dynamic changes in serum presepsin levels and mortality in immunocompromised patients with Sepsis: a prospective cohort study[J]. Diagnostics (Basel),2021,11(1):60. doi:  10.3390/diagnostics11010060
[20] KAPLAN M, DUZENLI T, TANOGLU A, et al. Presepsin: albumin ratio and C-reactive protein: albumin ratio as novel Sepsis-based prognostic scores: a retrospective study[J]. Wien Klin Wochenschr,2020,132(7-8):182-187. doi:  10.1007/s00508-020-01618-9
[21] SHIMOYAMA Y, UMEGAKI O, KADONO N, et al. Presepsin values predict septic acute kidney injury, acute respiratory distress syndrome, disseminated intravascular coagulation, and shock[J]. Shock,2021,55(4):501-506. doi:  10.1097/SHK.0000000000001664
[22] KOIZUMI Y, SAKANASHI D, MOHRI T, et al. Can presepsin uniformly respond to various pathogens? -an in vitro assay of new Sepsis marker[J]. BMC Immunol,2020,21(1):33. doi:  10.1186/s12865-020-00362-z
[23] GIBOT S, KOLOPP-SARDA M N, BÉNÉ M C, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected Sepsis[J]. Ann Intern Med,2004,141(1):9-15. doi:  10.7326/0003-4819-141-1-200407060-00009
[24] SU L X, HAN B C, LIU C T, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among Sepsis patients with new fever in intensive care units: a prospective cohort study[J]. BMC Infect Dis,2012,12:157. doi:  10.1186/1471-2334-12-157
[25] PONTRELLI G, DE CRESCENZO F, BUZZETTI R, et al. Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric Sepsis: a systematic review[J]. Ital J Pediatr,2016,42:44. doi:  10.1186/s13052-016-0242-y
[26] JOLLY L, CARRASCO K, DERIVE M, et al. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock[J]. Cardiovasc Res,2018,114(6):907-918. doi:  10.1093/cvr/cvy018
[27] GIBOT S, CRAVOISY A, KOLOPP-SARDA M N, et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during Sepsis[J]. Crit Care Med,2005,33(4):792-796. doi:  10.1097/01.CCM.0000159089.16462.4A
[28] ZHANG J, SHE D Y, FENG D, et al. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect Sepsis severity and can predict prognosis: a prospective study[J]. BMC Infect Dis,2011,11:53. doi:  10.1186/1471-2334-11-53
[29] CHARLES P E, NOEL R, MASSIN F, et al. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with Sepsis[J]. BMC Infect Dis,2016,16(1):559. doi:  10.1186/s12879-016-1893-4
[30] HUANG Q R, XIONG H Y, YAN P J, et al. The diagnostic and prognostic value of suPAR in patients with Sepsis: a systematic review and meta-analysis[J]. Shock,2020,53(4):416-425. doi:  10.1097/SHK.0000000000001434
[31] SHARMA A, RAY S, MAMIDIPALLI R, et al. A comparative study of the diagnostic and prognostic utility of soluble urokinase-type plasminogen activator receptor and procalcitonin in patients with Sepsis and systemic inflammation response syndrome[J]. Indian J Crit Care Med,2020,24(4):245-251. doi:  10.5005/jp-journals-10071-23385
[32] VELISSARIS D, DIMOPOULOS G, PARISSIS J, et al. Prognostic role of soluble urokinase plasminogen activator receptor at the emergency department: a position paper by the Hellenic Sepsis study group[J]. Infect Dis Ther,2020,9(3):407-416. doi:  10.1007/s40121-020-00301-w
[33] LAFON T, CAZALIS M A, VALLEJO C, et al. Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and Sepsis admitted to the emergency department[J]. Ann Intensive Care,2020,10(1):113. doi:  10.1186/s13613-020-00729-w
[34] PREGERNIG A, MÜLLER M, HELD U, et al. Prediction of mortality in adult patients with Sepsis using six biomarkers: a systematic review and meta-analysis[J]. Ann Intensive Care,2019,9(1):125. doi:  10.1186/s13613-019-0600-1
[35] WINTER J, JUNG S, KELLER S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation[J]. Nat Cell Biol,2009,11(3):228-234. doi:  10.1038/ncb0309-228
[36] EL-HEFNAWY S M, MOSTAFA R G, EL ZAYAT R S, et al. Biochemical and molecular study on serum miRNA-16a and miRNA- 451 as neonatal Sepsis biomarkers[J]. Biochem Biophys Rep,2021,25:100915.
[37] SUN B, LUAN C Y, GUO L S, et al. Low expression of microRNA-328 can predict Sepsis and alleviate Sepsis-induced cardiac dysfunction and inflammatory response[J]. Braz J Med Biol Res,2020,53(8):e9501. doi:  10.1590/1414-431x20209501
[38] HERMANN S, BRANDES F, KIRCHNER B, et al. Diagnostic potential of circulating cell-free microRNAs for community-acquired pneumonia and pneumonia-related Sepsis[J]. J Cell Mol Med,2020,24(20):12054-12064. doi:  10.1111/jcmm.15837
[39] ZHENG G, QIU G, GE M, et al. miR-10a in peripheral blood mononuclear cells is a biomarker for Sepsis and has anti-inflammatory function[J]. Mediators Inflamm,2020,2020:4370983.
[40] LI N, WU S S, YU L. The associations of long non-coding RNA taurine upregulated gene 1 and microRNA-223 with general disease severity and mortality risk in Sepsis patients[J]. Medicine (Baltimore),2020,99(50):e23444. doi:  10.1097/MD.0000000000023444
[41] ZHANG H, CHE L, WANG Y, et al. Deregulated microRNA-22-3p in patients with sepsis-induced acute kidney injury serves as a new biomarker to predict disease occurrence and 28-day survival outcomes[J]. Int Urol Nephrol,2021,53:2107-2116. doi:  10.1007/s11255-021-02784-z
[42] WU S Y, ZHANG H, WU W, et al. Value of serum miR-21-3p in predicting acute kidney injury in children with Sepsis[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2020, 22(3): 269-273. C: \Users\sxchen\Downloads\Chinese_https: \www.ncbi.nlm.nih.gov\pubmed\32204765\.
[43] CHEN M, WANG F, XIA H, et al. MicroRNA-155: regulation of immune cells in Sepsis[J]. Mediators Inflamm,2021,2021:8874854.
[44] LINK F, KROHN K, BURGDORFF A M, et al. Sepsis diagnostics: intensive care scoring systems superior to MicroRNA biomarker testing[J]. Diagnostics,2020,10(9):701. doi:  10.3390/diagnostics10090701
[45] HASHEMIAN S M, POURHANIFEH M H, FADAEI S, et al. Non-coding RNAs and exosomes: their role in the pathogenesis of Sepsis[J]. Mol Ther Nucleic Acids,2020,21:51-74. doi:  10.1016/j.omtn.2020.05.012
[46] ZHAO G, SU Z Y, SONG D, et al. The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-κB[J]. FEBS Lett,2016,590(17):2884-2895. doi:  10.1002/1873-3468.12315
[47] CHEN J J, HE Y F, ZHOU L L, et al. Long non-coding RNA MALAT1 serves as an independent predictive biomarker for the diagnosis, severity and prognosis of patients with Sepsis[J]. Mol Med Report,2020,21(3):1365-1373.
[48] XU Y H, SHAO B B. Circulating long noncoding RNA ZNFX1 antisense RNA negatively correlates with disease risk, severity, inflammatory markers, and predicts poor prognosis in Sepsis patients[J]. Medicine (Baltimore),2019,98(9):e14558. doi:  10.1097/MD.0000000000014558
[49] HE F, ZHANG C, HUANG Q. Long noncoding RNA nuclear enriched abundant transcript 1/miRNA-124 axis correlates with increased disease risk, elevated inflammation, deteriorative disease condition, and predicts decreased survival of Sepsis[J]. Medicine (Baltimore),2019,98(32):e16470. doi:  10.1097/MD.0000000000016470
[50] HUANG Q H, HUANG C Y, LUO Y, et al. Circulating lncRNA NEAT1 correlates with increased risk, elevated severity and unfavorable prognosis in Sepsis patients[J]. Am J Emerg Med,2018,36(9):1659-1663. doi:  10.1016/j.ajem.2018.06.008
[51] NA L, DING H J, XING E H, et al. Lnc-MEG3 Acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of Sepsis via interacting with miR-21[J]. J Clin Lab Anal,2020,34(4):e23123.
[52] LARSSON A, TYDÉN J, JOHANSSON J, et al. Calprotectin is superior to procalcitonin as a Sepsis marker and predictor of 30-day mortality in intensive care patients[J]. Scand J Clin Lab Invest,2020,80(2):156-161. doi:  10.1080/00365513.2019.1703216
[53] BARTÁKOVÁ E, ŠTEFAN M, STRÁNÍKOVÁ A, et al. Calprotectin and calgranulin C serum levels in bacterial Sepsis[J]. Diagn Microbiol Infect Dis,2019,93(3):219-226. doi:  10.1016/j.diagmicrobio.2018.10.006
[54] WIRTZ T H, BUENDGENS L, WEISKIRCHEN R, et al. Association of serum calprotectin concentrations with mortality in critically ill and septic patients[J]. Diagnostics,2020,10(11):990. doi:  10.3390/diagnostics10110990
[55] HASHEM H E, ABDEL HALIM R M, EL MASRY S A, et al. The utility of neutrophil CD64 and presepsin as diagnostic, prognostic, and monitoring biomarkers in neonatal Sepsis[J]. Int J Microbiol,2020,2020:8814892.
[56] HASHEM H E, EL MASRY S A, MOKHTAR A M, et al. Valuable role of neutrophil CD64 and highly sensitive CRP biomarkers for diagnostic, monitoring, and prognostic evaluations of Sepsis patients in neonatal ICUs[J]. Biomed Res Int,2020,2020:6214363.
[57] YIN W P, LI J B, ZHENG X F, et al. Effect of neutrophil CD64 for diagnosing Sepsis in emergency department[J]. World J Emerg Med,2020,11(2):79-86. doi:  10.5847/wjem.j.1920-8642.2020.02.003
[58] EL MANOUNI EL HASSANI S, NIEMARKT H J, BERKHOUT D J C, et al. Profound pathogen-specific alterations in intestinal microbiota composition precede late-onset Sepsis in preterm infants: a longitudinal, multicenter, case-control study[J]. Clin Infect Dis,2021,73(1):e224-e232. doi:  10.1093/cid/ciaa1635
[59] AGUDELO-OCHOA G M, VALDÉS-DUQUE B E, GIRALDO-GIRALDO N A, et al. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for Sepsis[J]. Gut Microbes,2020,12(1):1707610. doi:  10.1080/19490976.2019.1707610
[60] YIN L, WAN Y D, PAN X T, et al. Association between gut bacterial diversity and mortality in septic shock patients: a cohort study[J]. Med Sci Monit,2019,25:7376-7382. doi:  10.12659/MSM.916808
[61] LELIGDOWICZ A, RICHARD-GREENBLATT M, WRIGHT J, et al. Endothelial activation: the ang/Tie axis in Sepsis[J]. Front Immunol,2018,9:838. doi:  10.3389/fimmu.2018.00838
[62] SEOL C H, YONG S H, SHIN J H, et al. The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with Sepsis[J]. Cytokine,2020,129:155029. doi:  10.1016/j.cyto.2020.155029